APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs Targeting SLC Transporters

Compare research editions
View pricing & licenses

Selected research

Industry Research

Drugs Targeting SLC Transporters Industry Research Report 2026

22 December 2025120 pages

Choose your research edition.

Industry ResearchDrugs Targeting SLC Transporters Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs Targeting SLC Transporters Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drugs Targeting SLC Transporters Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs Targeting SLC Transporters Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs Targeting SLC Transporters Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Drugs Targeting SLC Transporters market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Drugs Targeting SLC Transporters is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Drugs Targeting SLC Transporters is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Drugs Targeting SLC Transporters is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Drugs Targeting SLC Transporters include Zhengda Tianqing, Janssen Pharmaceuticals, Sandoz, Johnson & Johnson, Merck, Kelun Pharmaceutical, Bristol-Myers Squibb, AstraZeneca and Starpharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Drugs Targeting SLC Transporters market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Drugs Targeting SLC Transporters Market by Company

Zhengda Tianqing

Janssen Pharmaceuticals

Sandoz

Johnson & Johnson

Merck

Kelun Pharmaceutical

Bristol-Myers Squibb

AstraZeneca

Starpharma

Orifarm

Jnana Therapeutics

Hengrui

Hansoh Pharmaceuticals

Boehringer Ingelheim

Drugs Targeting SLC Transporters Segment by Type

SGLT-2 Inhibitors

Antidepressants

Diuretics

Drugs Targeting SLC Transporters Segment by Application

Hospital

Clinic

Drugs Targeting SLC Transporters Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Targeting SLC Transporters market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Targeting SLC Transporters and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Targeting SLC Transporters.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Drugs Targeting SLC Transporters manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Drugs Targeting SLC Transporters by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Drugs Targeting SLC Transporters in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drugs Targeting SLC Transporters Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Drugs Targeting SLC Transporters Sales (k units) of Manufacturers (2021-2026) Table 7. Global Drugs Targeting SLC Transporters Sales Market Share by Manufacturers (2021-2026) Table 8. Global Drugs Targeting SLC Transporters Revenue of Manufacturers (2021-2026) Table 9. Global Drugs Targeting SLC Transporters Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Drugs Targeting SLC Transporters Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Drugs Targeting SLC Transporters Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Drugs Targeting SLC Transporters, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Drugs Targeting SLC Transporters, Product Type & Application Table 14. Global Drugs Targeting SLC Transporters Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Drugs Targeting SLC Transporters by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhengda Tianqing Company Information Table 19. Zhengda Tianqing Business Overview Table 20. Zhengda Tianqing Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zhengda Tianqing Drugs Targeting SLC Transporters Product Portfolio Table 22. Zhengda Tianqing Recent Developments Table 23. Janssen Pharmaceuticals Company Information Table 24. Janssen Pharmaceuticals Business Overview Table 25. Janssen Pharmaceuticals Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Janssen Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio Table 27. Janssen Pharmaceuticals Recent Developments Table 28. Sandoz Company Information Table 29. Sandoz Business Overview Table 30. Sandoz Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Sandoz Drugs Targeting SLC Transporters Product Portfolio Table 32. Sandoz Recent Developments Table 33. Johnson & Johnson Company Information Table 34. Johnson & Johnson Business Overview Table 35. Johnson & Johnson Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Johnson & Johnson Drugs Targeting SLC Transporters Product Portfolio Table 37. Johnson & Johnson Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Merck Drugs Targeting SLC Transporters Product Portfolio Table 42. Merck Recent Developments Table 43. Kelun Pharmaceutical Company Information Table 44. Kelun Pharmaceutical Business Overview Table 45. Kelun Pharmaceutical Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Kelun Pharmaceutical Drugs Targeting SLC Transporters Product Portfolio Table 47. Kelun Pharmaceutical Recent Developments Table 48. Bristol-Myers Squibb Company Information Table 49. Bristol-Myers Squibb Business Overview Table 50. Bristol-Myers Squibb Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Bristol-Myers Squibb Drugs Targeting SLC Transporters Product Portfolio Table 52. Bristol-Myers Squibb Recent Developments Table 53. AstraZeneca Company Information Table 54. AstraZeneca Business Overview Table 55. AstraZeneca Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. AstraZeneca Drugs Targeting SLC Transporters Product Portfolio Table 57. AstraZeneca Recent Developments Table 58. Starpharma Company Information Table 59. Starpharma Business Overview Table 60. Starpharma Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Starpharma Drugs Targeting SLC Transporters Product Portfolio Table 62. Starpharma Recent Developments Table 63. Orifarm Company Information Table 64. Orifarm Business Overview Table 65. Orifarm Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Orifarm Drugs Targeting SLC Transporters Product Portfolio Table 67. Orifarm Recent Developments Table 68. Jnana Therapeutics Company Information Table 69. Jnana Therapeutics Business Overview Table 70. Jnana Therapeutics Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Jnana Therapeutics Drugs Targeting SLC Transporters Product Portfolio Table 72. Jnana Therapeutics Recent Developments Table 73. Hengrui Company Information Table 74. Hengrui Business Overview Table 75. Hengrui Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Hengrui Drugs Targeting SLC Transporters Product Portfolio Table 77. Hengrui Recent Developments Table 78. Hansoh Pharmaceuticals Company Information Table 79. Hansoh Pharmaceuticals Business Overview Table 80. Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio Table 82. Hansoh Pharmaceuticals Recent Developments Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Drugs Targeting SLC Transporters Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Drugs Targeting SLC Transporters Product Portfolio Table 87. Boehringer Ingelheim Recent Developments Table 88. Global Drugs Targeting SLC Transporters Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Drugs Targeting SLC Transporters Sales by Region (2021-2026) & (k units) Table 90. Global Drugs Targeting SLC Transporters Sales Market Share by Region (2021-2026) Table 91. Global Drugs Targeting SLC Transporters Sales by Region (2027-2032) & (k units) Table 92. Global Drugs Targeting SLC Transporters Sales Market Share by Region (2027-2032) Table 93. Global Drugs Targeting SLC Transporters Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Drugs Targeting SLC Transporters Revenue Market Share by Region (2021-2026) Table 95. Global Drugs Targeting SLC Transporters Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Drugs Targeting SLC Transporters Revenue Market Share by Region (2027-2032) Table 97. North America Drugs Targeting SLC Transporters Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 99. North America Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 100. North America Drugs Targeting SLC Transporters Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Drugs Targeting SLC Transporters Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Drugs Targeting SLC Transporters Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 104. Europe Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 105. Europe Drugs Targeting SLC Transporters Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Drugs Targeting SLC Transporters Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Drugs Targeting SLC Transporters Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Drugs Targeting SLC Transporters Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Drugs Targeting SLC Transporters Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Drugs Targeting SLC Transporters Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 114. South America Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 115. South America Drugs Targeting SLC Transporters Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Drugs Targeting SLC Transporters Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Drugs Targeting SLC Transporters Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Drugs Targeting SLC Transporters Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Drugs Targeting SLC Transporters Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Drugs Targeting SLC Transporters Sales by Type (2021-2026) & (k units) Table 123. Global Drugs Targeting SLC Transporters Sales by Type (2027-2032) & (k units) Table 124. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2026) Table 125. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2027-2032) Table 126. Global Drugs Targeting SLC Transporters Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Drugs Targeting SLC Transporters Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2026) Table 129. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2027-2032) Table 130. Global Drugs Targeting SLC Transporters Price by Type (2021-2026) & (US$/unit) Table 131. Global Drugs Targeting SLC Transporters Price by Type (2027-2032) & (US$/unit) Table 132. Global Drugs Targeting SLC Transporters Sales by Application (2021-2026) & (k units) Table 133. Global Drugs Targeting SLC Transporters Sales by Application (2027-2032) & (k units) Table 134. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2026) Table 135. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2027-2032) Table 136. Global Drugs Targeting SLC Transporters Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Drugs Targeting SLC Transporters Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2026) Table 139. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2027-2032) Table 140. Global Drugs Targeting SLC Transporters Price by Application (2021-2026) & (US$/unit) Table 141. Global Drugs Targeting SLC Transporters Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Drugs Targeting SLC Transporters Distributors List Table 145. Drugs Targeting SLC Transporters Customers List Table 146. Drugs Targeting SLC Transporters Industry Trends Table 147. Drugs Targeting SLC Transporters Industry Drivers Table 148. Drugs Targeting SLC Transporters Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Drugs Targeting SLC Transporters Product Image Figure 5. Global Drugs Targeting SLC Transporters Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Drugs Targeting SLC Transporters Market Size (2021-2032) & (US$ Million) Figure 7. Global Drugs Targeting SLC Transporters Sales (2021-2032) & (k units) Figure 8. Global Drugs Targeting SLC Transporters Average Price (US$/unit) & (2021-2032) Figure 9. SGLT-2 Inhibitors Product Image Figure 10. Antidepressants Product Image Figure 11. Diuretics Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Global Drugs Targeting SLC Transporters Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Drugs Targeting SLC Transporters, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Drugs Targeting SLC Transporters Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drugs Targeting SLC Transporters Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Drugs Targeting SLC Transporters Sales by Region in 2025 Figure 20. Global Drugs Targeting SLC Transporters Revenue by Region in 2025 Figure 21. North America Drugs Targeting SLC Transporters Market Size by Country in 2025 Figure 22. North America Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 23. North America Drugs Targeting SLC Transporters Revenue Market Share by Country (2021-2032) Figure 24. United States Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Drugs Targeting SLC Transporters Market Size by Country in 2025 Figure 28. Europe Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 29. Europe Drugs Targeting SLC Transporters Revenue Market Share by Country (2021-2032) Figure 30. Germany Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Drugs Targeting SLC Transporters Market Size by Country in 2025 Figure 41. Asia Pacific Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Drugs Targeting SLC Transporters Revenue Market Share by Country (2021-2032) Figure 43. China Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Drugs Targeting SLC Transporters Market Size by Country in 2025 Figure 52. South America Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 53. South America Drugs Targeting SLC Transporters Revenue Market Share by Country (2021-2032) Figure 54. Brazil Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Drugs Targeting SLC Transporters Market Size by Country in 2025 Figure 58. Middle East and Africa Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Drugs Targeting SLC Transporters Revenue Market Share by Country (2021-2032) Figure 60. Egypt Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Drugs Targeting SLC Transporters Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2032) Figure 66. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2032) Figure 67. Global Drugs Targeting SLC Transporters Price (US$/unit) by Type (2021-2032) Figure 68. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2032) Figure 69. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2032) Figure 70. Global Drugs Targeting SLC Transporters Price (US$/unit) by Application (2021-2032) Figure 71. Drugs Targeting SLC Transporters Value Chain Figure 72. Drugs Targeting SLC Transporters Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Drugs Targeting SLC Transporters Industry Opportunities and Challenges

Scope & coverage.

Types
  • SGLT-2 Inhibitors
  • Antidepressants
  • Diuretics
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhengda Tianqing
  • Janssen Pharmaceuticals
  • Sandoz
  • Johnson & Johnson
  • Merck
  • Kelun Pharmaceutical
  • Bristol-Myers Squibb
  • AstraZeneca
  • Starpharma
  • Orifarm
  • Jnana Therapeutics
  • Hengrui
  • Hansoh Pharmaceuticals
  • Boehringer Ingelheim

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Drugs Targeting SLC Transporters Market Size (2021-2032)
  4. 2.2.2 Global Drugs Targeting SLC Transporters Sales (2021-2032)
  5. 2.2.3 Global Drugs Targeting SLC Transporters Market Average Price (2021-2032)
  6. 2.3 Drugs Targeting SLC Transporters by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 SGLT-2 Inhibitors
  9. 2.3.3 Antidepressants
  10. 2.3.4 Diuretics
  11. 2.4 Drugs Targeting SLC Transporters by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Drugs Targeting SLC Transporters Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Drugs Targeting SLC Transporters Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Drugs Targeting SLC Transporters Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Drugs Targeting SLC Transporters Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Drugs Targeting SLC Transporters Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Drugs Targeting SLC Transporters, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Drugs Targeting SLC Transporters, Product Type & Application
  8. 3.8 Global Manufacturers of Drugs Targeting SLC Transporters, Established Date
  9. 3.9 Global Drugs Targeting SLC Transporters Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhengda Tianqing
  2. 4.1.1 Zhengda Tianqing Company Information
  3. 4.1.2 Zhengda Tianqing Business Overview
  4. 4.1.3 Zhengda Tianqing Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhengda Tianqing Drugs Targeting SLC Transporters Product Portfolio
  6. 4.1.5 Zhengda Tianqing Recent Developments
  7. 4.2 Janssen Pharmaceuticals
  8. 4.2.1 Janssen Pharmaceuticals Company Information
  9. 4.2.2 Janssen Pharmaceuticals Business Overview
  10. 4.2.3 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio
  12. 4.2.5 Janssen Pharmaceuticals Recent Developments
  13. 4.3 Sandoz
  14. 4.3.1 Sandoz Company Information
  15. 4.3.2 Sandoz Business Overview
  16. 4.3.3 Sandoz Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sandoz Drugs Targeting SLC Transporters Product Portfolio
  18. 4.3.5 Sandoz Recent Developments
  19. 4.4 Johnson & Johnson
  20. 4.4.1 Johnson & Johnson Company Information
  21. 4.4.2 Johnson & Johnson Business Overview
  22. 4.4.3 Johnson & Johnson Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Johnson & Johnson Drugs Targeting SLC Transporters Product Portfolio
  24. 4.4.5 Johnson & Johnson Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Drugs Targeting SLC Transporters Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 Kelun Pharmaceutical
  32. 4.6.1 Kelun Pharmaceutical Company Information
  33. 4.6.2 Kelun Pharmaceutical Business Overview
  34. 4.6.3 Kelun Pharmaceutical Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Kelun Pharmaceutical Drugs Targeting SLC Transporters Product Portfolio
  36. 4.6.5 Kelun Pharmaceutical Recent Developments
  37. 4.7 Bristol-Myers Squibb
  38. 4.7.1 Bristol-Myers Squibb Company Information
  39. 4.7.2 Bristol-Myers Squibb Business Overview
  40. 4.7.3 Bristol-Myers Squibb Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Bristol-Myers Squibb Drugs Targeting SLC Transporters Product Portfolio
  42. 4.7.5 Bristol-Myers Squibb Recent Developments
  43. 4.8 AstraZeneca
  44. 4.8.1 AstraZeneca Company Information
  45. 4.8.2 AstraZeneca Business Overview
  46. 4.8.3 AstraZeneca Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AstraZeneca Drugs Targeting SLC Transporters Product Portfolio
  48. 4.8.5 AstraZeneca Recent Developments
  49. 4.9 Starpharma
  50. 4.9.1 Starpharma Company Information
  51. 4.9.2 Starpharma Business Overview
  52. 4.9.3 Starpharma Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Starpharma Drugs Targeting SLC Transporters Product Portfolio
  54. 4.9.5 Starpharma Recent Developments
  55. 4.10 Orifarm
  56. 4.10.1 Orifarm Company Information
  57. 4.10.2 Orifarm Business Overview
  58. 4.10.3 Orifarm Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Orifarm Drugs Targeting SLC Transporters Product Portfolio
  60. 4.10.5 Orifarm Recent Developments
  61. 4.11 Jnana Therapeutics
  62. 4.11.1 Jnana Therapeutics Company Information
  63. 4.11.2 Jnana Therapeutics Business Overview
  64. 4.11.3 Jnana Therapeutics Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jnana Therapeutics Drugs Targeting SLC Transporters Product Portfolio
  66. 4.11.5 Jnana Therapeutics Recent Developments
  67. 4.12 Hengrui
  68. 4.12.1 Hengrui Company Information
  69. 4.12.2 Hengrui Business Overview
  70. 4.12.3 Hengrui Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hengrui Drugs Targeting SLC Transporters Product Portfolio
  72. 4.12.5 Hengrui Recent Developments
  73. 4.13 Hansoh Pharmaceuticals
  74. 4.13.1 Hansoh Pharmaceuticals Company Information
  75. 4.13.2 Hansoh Pharmaceuticals Business Overview
  76. 4.13.3 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio
  78. 4.13.5 Hansoh Pharmaceuticals Recent Developments
  79. 4.14 Boehringer Ingelheim
  80. 4.14.1 Boehringer Ingelheim Company Information
  81. 4.14.2 Boehringer Ingelheim Business Overview
  82. 4.14.3 Boehringer Ingelheim Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Boehringer Ingelheim Drugs Targeting SLC Transporters Product Portfolio
  84. 4.14.5 Boehringer Ingelheim Recent Developments
5 Global Drugs Targeting SLC Transporters Market Scenario by Region
  1. 5.1 Global Drugs Targeting SLC Transporters Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Drugs Targeting SLC Transporters Sales by Region: 2021-2032
  3. 5.2.1 Global Drugs Targeting SLC Transporters Sales by Region: 2021-2026
  4. 5.2.2 Global Drugs Targeting SLC Transporters Sales by Region: 2027-2032
  5. 5.3 Global Drugs Targeting SLC Transporters Revenue by Region: 2021-2032
  6. 5.3.1 Global Drugs Targeting SLC Transporters Revenue by Region: 2021-2026
  7. 5.3.2 Global Drugs Targeting SLC Transporters Revenue by Region: 2027-2032
  8. 5.4 North America Drugs Targeting SLC Transporters Market Facts & Figures by Country
  9. 5.4.1 North America Drugs Targeting SLC Transporters Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  11. 5.4.3 North America Drugs Targeting SLC Transporters Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Drugs Targeting SLC Transporters Market Facts & Figures by Country
  16. 5.5.1 Europe Drugs Targeting SLC Transporters Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  18. 5.5.3 Europe Drugs Targeting SLC Transporters Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Drugs Targeting SLC Transporters Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Drugs Targeting SLC Transporters Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Drugs Targeting SLC Transporters Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Drugs Targeting SLC Transporters Market Facts & Figures by Country
  41. 5.7.1 South America Drugs Targeting SLC Transporters Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  43. 5.7.3 South America Drugs Targeting SLC Transporters Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Drugs Targeting SLC Transporters Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Drugs Targeting SLC Transporters Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Drugs Targeting SLC Transporters Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Drugs Targeting SLC Transporters Sales by Type (2021-2032)
  2. 6.1.1 Global Drugs Targeting SLC Transporters Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2032)
  4. 6.2 Global Drugs Targeting SLC Transporters Revenue by Type (2021-2032)
  5. 6.2.1 Global Drugs Targeting SLC Transporters Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Drugs Targeting SLC Transporters Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Drugs Targeting SLC Transporters Sales by Application (2021-2032)
  2. 7.1.1 Global Drugs Targeting SLC Transporters Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2032)
  4. 7.2 Global Drugs Targeting SLC Transporters Revenue by Application (2021-2032)
  5. 7.2.1 Global Drugs Targeting SLC Transporters Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Drugs Targeting SLC Transporters Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Drugs Targeting SLC Transporters Value Chain Analysis
  2. 8.1.1 Drugs Targeting SLC Transporters Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Drugs Targeting SLC Transporters Production Mode & Process
  5. 8.2 Drugs Targeting SLC Transporters Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Drugs Targeting SLC Transporters Distributors
  8. 8.2.3 Drugs Targeting SLC Transporters Customers
9 Global Drugs Targeting SLC Transporters Analyzing Market Dynamics
  1. 9.1 Drugs Targeting SLC Transporters Industry Trends
  2. 9.2 Drugs Targeting SLC Transporters Industry Drivers
  3. 9.3 Drugs Targeting SLC Transporters Industry Opportunities and Challenges
  4. 9.4 Drugs Targeting SLC Transporters Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst